BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11427611)

  • 1. Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class compounds.
    Hawser SP; Jessup C; Vitullo J; Ghannoum MA
    J Clin Microbiol; 2001 Jul; 39(7):2738-41. PubMed ID: 11427611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE;
    J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.
    Ahmed AO; van de Sande WW; van Vianen W; van Belkum A; Fahal AH; Verbrugh HA; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2742-6. PubMed ID: 15215141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.
    van de Sande WW; Luijendijk A; Ahmed AO; Bakker-Woudenberg IA; van Belkum A
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1364-8. PubMed ID: 15793113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
    Shehata AS; Mukherjee PK; Ghannoum MA
    J Clin Microbiol; 2008 Nov; 46(11):3668-71. PubMed ID: 18832129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of 2,3-bis [2-methyloxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide (XTT) and 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2, 4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8) rapid colorimetric assays for antimicrobial susceptibility testing of staphylococci and ESBL-producing clinical isolates.
    Brady AJ; Kearney P; Tunney MM
    J Microbiol Methods; 2007 Dec; 71(3):305-11. PubMed ID: 17963904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay as rapid colorimetric method for determination of antibiotic susceptibility of clinical Mycobacterium tuberculosis isolates in liquid medium.
    De Logu A; Borgna R; Uda P; Sanna A; Pellerano ML; Saddi B
    Clin Lab; 2003; 49(7-8):357-65. PubMed ID: 12908735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.
    Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Mar; 51(3):881-7. PubMed ID: 17145783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Marker of Echinocandin Activity in an
    Meletiadis J; Siopi M; Tsakris A; Mouton JW; Pournaras S
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus.
    Chiou CC; Mavrogiorgos N; Tillem E; Hector R; Walsh TJ
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3310-21. PubMed ID: 11709302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents.
    Hawser SP; Norris H; Jessup CJ; Ghannoum MA
    J Clin Microbiol; 1998 May; 36(5):1450-2. PubMed ID: 9574729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel echinocandin antifungals. Part 2: Optimization of the side chain of the natural product FR901379. Discovery of micafungin.
    Tomishima M; Ohki H; Yamada A; Maki K; Ikeda F
    Bioorg Med Chem Lett; 2008 May; 18(9):2886-90. PubMed ID: 18424132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorimetric assay for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly JP; Verweij PE;
    J Clin Microbiol; 2001 Sep; 39(9):3402-8. PubMed ID: 11526191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J; Peláez T; Alcalá L; Bouza E
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
    Chamilos G; Kontoyiannis DP
    Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
    Lewis RE; Kontoyiannis DP
    J Antimicrob Chemother; 2005 Nov; 56(5):887-92. PubMed ID: 16188916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus.
    Choi JH; Brummer E; Stevens DA
    Microbes Infect; 2004 Apr; 6(4):383-9. PubMed ID: 15050966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigm.
    Brun YF; Dennis CG; Greco WR; Bernacki RJ; Pera PJ; Bushey JJ; Youn RC; White DB; Segal BH
    Antimicrob Agents Chemother; 2007 May; 51(5):1804-12. PubMed ID: 17325217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A colorimetric and spectrophotometric method for in vitro susceptibility testing of Aspergillus species against caspofungin.
    Te Dorsthorst DT; Zwaaftink RB; Rijs AJ; Meletiadis J; Verweij PE
    Med Mycol; 2007 Jun; 45(4):351-5. PubMed ID: 17510858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.
    Espinel-Ingroff A; Fothergill A; Ghannoum M; Manavathu E; Ostrosky-Zeichner L; Pfaller MA; Rinaldi MG; Schell W; Walsh TJ
    J Clin Microbiol; 2007 Jul; 45(7):2180-2. PubMed ID: 17475760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.